Pulse Oximetry FAQ

This FAQ has been compiled by our team of experts. Please submit your questions at the bottom of this page!

What is the meaning of ‘substantially equivalent’ for FDA approval?

To receive FDA approval on a new device intended for human use, a premarket submission called a 510k must be made to the FDA. This must demonstrate that the device is substantially equivalent to a legally marketed device, meaning that it is just as safe and effective.

According to the FDA, a device is considered “substantially equivalent” if the following criteria are met: 

  • Has the same intended use as the predicate device; and
  • Has the same technological characteristics as the predicate;
    OR
  • Has the same intended use as the predicate; and
  • Has different technological characteristics and does not raise different questions of safety and effectiveness; and
  • The device is demonstrated to be as safe and effective as the legally marketed device

Once this information has been submitted to the FDA, the FDA will determine whether the device is safe and effective through a thorough review process, including evaluation of performance data and technological characteristics. In the US, a device may not be marketed until the FDA determines that substantial equivalence is present.

References: FDA Premarket Notification 510(k)

Keywords: substantially equivalent, SE, FDA, 510k

You have additional questions?

About Oximeter Database Oximetry FAQ Study Protocols Publications